My watch list
my.bionity.com  
Login  

1,985 Current news from israel

rss
matching the following criteria

Adenosine can melt "love handles"

20-10-2014

The number of overweight persons is greatly increasing worldwide - and as a result is the risk of suffering a heart attack, stroke, diabetes or Alzheimer's disease. For this reason, many people dream of an efficient method for losing weight. An international team of researchers led by Professor ...

more

image description
Researchers Identify “Naïve-Like” Human Stem Cells

20-10-2014

In their search for the earliest possible stage of development of human embryonic stem cells (hESCs) that still have the potential to develop into any types of body cells and tissue, researchers from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, and the University of ...

more

Immune cells in the liver drive fatty liver disease and liver cancer

17-10-2014

Immune cells that migrate to the liver and interact there with liver tissue cells get activated by metabolic stress (e.g. through lipids of a high fat diet) and drive the development of fatty liver disease, non-alcoholic steatohepatitis and liver cancer. Scientists from the Helmholtz Zentrum ...

more

Sucessful Spin-Out of ImevaX GmbH from the Technische Universität München

17-10-2014

ImevaX GmbH commenced its research and development activities in their own premises in Munich on Sep. 1st, 2014. With this step, ImevaX realized a successful spin-out from the Technische Universität München (TUM). A key factor for the success of the founder Professor Markus Gerhard and his team, ...

more

Vetter Announces Personnel Changes in its Development Service Division

Clinical manufacturing services continue to attract new business

17-10-2014

Vetter officially announced a series of adjustments to its Development Service related structures designed to support its customer base. Effective October 1, Dr. Susanne Resatz, formerly Manager Process Development and Manufacturing at the company’s clinical development facility in Chicago, ...

more

WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche

16-10-2014

WILEX AG announced that WILEX subsidiary Heidelberg Pharma and Roche extended the existing 2013 licence agreement to apply the antibody drug conjugate (ADC) technology for the further development of Roche antibodies. The aim is to identify and develop novel AntibodyTargeted Amanitin Conjugates ...

more

Parkinson: How toxic proteins stress nerve cells

Biomarkers and target proteins identified in vulnerable neurons

16-10-2014

Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded ...

more

New Oncology and Gustave Roussy Announce Collaboration on Genetic Testing

15-10-2014

New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, Paris. Under this agreement, New Oncology will perform comprehensive parallel multigene testing to identify therapeutically relevant alterations in cancer-related genes. New Oncology will ...

more

image description
New antibiotic against hospital-acquired pathogens

Scientists discover substances effective against multi-resistant pathogens

14-10-2014

Multi-resistant staphylococci are amongst the most feared pathogens in hospitals since they respond to therapy only very little or not at all any more. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and of the Helmholtz Centre for Infection Research (HZI), ...

more

Vaccination as simple as putting on lotion

Nanotechnology lets vaccines get into the body without a pinprick

14-10-2014

According to usual technique, vaccines are introduced into the body by means of a needle. A search for alternative methods has been ongoing for a few years already for a number of reasons. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and of the Helmholtz ...

more

Page 1 From 199
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE